These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 18534623

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Salivary cortisol in panic: are males more vulnerable?
    van Duinen MA, Schruers KR, Jaegers E, Maes M, Griez EJ.
    Neuro Endocrinol Lett; 2004 Oct; 25(5):386-90. PubMed ID: 15580175
    [Abstract] [Full Text] [Related]

  • 23. Sensitivity to cholecystokinin-tetrapeptide in major depression.
    Koszycki D, Copen J, Bradwejn J.
    J Affect Disord; 2004 Jun; 80(2-3):285-90. PubMed ID: 15207943
    [Abstract] [Full Text] [Related]

  • 24. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
    Daumann J, Till B, Fischermann T, Rezk M, Gouzoulis-Mayfrank E.
    J Psychopharmacol; 2006 Mar; 20(2):236-44. PubMed ID: 16510481
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of repeat exposure on neuroendocrine and symptom responses to pentagastrin.
    Khan S, Liberzon I, Abelson JL.
    Psychiatry Res; 2004 May 30; 126(3):189-95. PubMed ID: 15157745
    [Abstract] [Full Text] [Related]

  • 27. Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers.
    Zwanzger P, Baghai TC, Schuele C, Ströhle A, Padberg F, Kathmann N, Schwarz M, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2001 Nov 30; 25(5):699-703. PubMed ID: 11682253
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Neurohormonal responses to cholecystokinin tetrapeptide: a comparison of younger and older healthy subjects.
    Flint AJ, Koszycki D, Bradwejn J, Vaccarino FJ.
    Psychoneuroendocrinology; 2000 Aug 30; 25(6):633-47. PubMed ID: 10840174
    [Abstract] [Full Text] [Related]

  • 30. Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers.
    Zwanzger P, Eser D, Padberg F, Baghai TC, Schule C, Rötzer F, Ella R, Möller HJ, Rupprecht R.
    Depress Anxiety; 2003 Aug 30; 18(3):140-3. PubMed ID: 14625878
    [Abstract] [Full Text] [Related]

  • 31. Loudness dependence of the auditory evoked N1/P2 component as an indicator of serotonergic dysfunction in patients with schizophrenia--a replication study.
    Juckel G, Gudlowski Y, Müller D, Ozgürdal S, Brüne M, Gallinat J, Frodl T, Witthaus H, Uhl I, Wutzler A, Pogarell O, Mulert C, Hegerl U, Meisenzahl EM.
    Psychiatry Res; 2008 Feb 28; 158(1):79-82. PubMed ID: 18096246
    [Abstract] [Full Text] [Related]

  • 32. Clinical characteristics associated with different strengths of loudness dependence of auditory evoked potentials (LDAEP) in major depressive disorder.
    Min JA, Lee SH, Lee SY, Chae JH, Lee CU, Park YM, Bae SM.
    Psychiatry Res; 2012 Dec 30; 200(2-3):374-81. PubMed ID: 23021319
    [Abstract] [Full Text] [Related]

  • 33. Clinical implications of loudness dependence of auditory evoked potentials in patients with atypical depression.
    Lee SH, Park YC, Yoon S, Kim JI, Hahn SW.
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct 03; 54():7-12. PubMed ID: 24865151
    [Abstract] [Full Text] [Related]

  • 34. Scalp- and sLORETA-derived loudness dependence of auditory evoked potentials (LDAEPs) in unmedicated depressed males and females and healthy controls.
    Jaworska N, Blier P, Fusee W, Knott V.
    Clin Neurophysiol; 2012 Sep 03; 123(9):1769-78. PubMed ID: 22425485
    [Abstract] [Full Text] [Related]

  • 35. Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers.
    Maron E, Tõru I, Tasa G, Must A, Toover E, Lang A, Vasar V, Shlik J.
    Neurosci Lett; 2008 Dec 03; 446(2-3):88-92. PubMed ID: 18832011
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4).
    Zwanzger P, Eser D, Völkel N, Baghai TC, Möller HJ, Rupprecht R, Padberg F.
    Int J Neuropsychopharmacol; 2007 Apr 03; 10(2):285-9. PubMed ID: 16817979
    [Abstract] [Full Text] [Related]

  • 38. Neuropeptide S receptor gene variation modulates anterior cingulate cortex Glx levels during CCK-4 induced panic.
    Ruland T, Domschke K, Schütte V, Zavorotnyy M, Kugel H, Notzon S, Vennewald N, Ohrmann P, Arolt V, Pfleiderer B, Zwanzger P.
    Eur Neuropsychopharmacol; 2015 Oct 03; 25(10):1677-82. PubMed ID: 26235955
    [Abstract] [Full Text] [Related]

  • 39. Central cholecystokinin activity in irritable bowel syndrome, panic disorder, and healthy controls.
    Koszycki D, Torres S, Swain JE, Bradwejn J.
    Psychosom Med; 2005 Oct 03; 67(4):590-5. PubMed ID: 16046372
    [Abstract] [Full Text] [Related]

  • 40. Uncoupling of sympathetic nervous system and hypothalamic-pituitary-adrenal axis in cirrhosis.
    Wiest R, Moleda L, Zietz B, Hellerbrand C, Schölmerich J, Straub R.
    J Gastroenterol Hepatol; 2008 Dec 03; 23(12):1901-8. PubMed ID: 18554237
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.